# US 2010/0166882 A1 · Composition comprising egg white-chalcanthite for preventing or treating cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166882 A1
- Document ID: US20100166882A1
- Status: Published application
- Kind: A1
- Application number: 12/398,865
- Filed: 2009-03-05
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: Eun A. Choi
- Inventors: Eun A. Choi
- Web page: https://patentgrep.com/patent/US20100166882A1

## CPC

- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 33/34: Copper; Compounds thereof
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention relates to a composition comprising an egg white-chalcanthite component for preventing or treating cancer, and more particularly, to a composition for preventing or treating cancer, which comprises egg white-chalcanthite prepared by mixing a roasted chalcanthite with egg white to reduce the toxicity of the chalcanthite or comprises a mixture of the egg white-chalcanthite and a bamboo salt, and a method for preparing the same. The composition comprising the egg white-chalcanthite exhibits excellent anti-cancer activity, and thus is usefully applicable to pharmaceutical preparations for preventing or treating cancer or the manufacture of health functional foods.

## Claims

### Claim 1

A pharmaceutical composition, comprising an egg white-chalcanthite as an effective component.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a bamboo salt.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the egg white-chalcanthite is powdered.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the egg white-chalcanthite and the bamboo salt are powdered.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the composition comprises the egg white-chalcanthite and the bamboo salt at a ratio of approximately 1:5 to approximately 1:50 by weight.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the egg white-chalcanthite is prepared by roasting the chalcanthite, dehydrating the roasted chalcanthite, pulverizing the dehydrated chalcanthite, and mixing the pulverized chalcanthite with egg white.

### Claim 7 (depends on 1)

The composition of claim 1, further comprising a pharmaceutically acceptable carrier.

### Claim 8 (depends on 2)

The composition of claim 2, further comprising a pharmaceutically acceptable carrier.

### Claim 9

A health functional food for, comprising egg white-chalcanthite as an effective component.

### Claim 10 (depends on 9)

The health functional food of claim 9, further comprising a bamboo salt.

### Claim 11

A method for preparing egg white-chalcanthite, the method comprising:
heating and dehydrating a chalcanthite, until the entire chalcanthite turns grey;
cooling the dehydrated chalcanthite;
pulverizing the chalcanthite; and
mixing the chalcanthite with egg white.

### Claim 12 (depends on 11)

The method of claim 11, further comprising, after mixing the chalcanthite with egg white, cooling the egg white-chalcanthite mixture, and pulverizing the mixture.

### Claim 13 (depends on 11)

The method of claim 11, wherein the ratio of chalcanthite to egg white is the same proportion as when 600 g of the dehydrated chalcanthite powder is mixed with from 140 g to 400 g of egg white.

### Claim 14 (depends on 1)

A method of increasing caspase-3 activity in a subject comprising administering an effective amount of the composition of claim 1 to the subject.

### Claim 15 (depends on 1)

A method of inhibiting growth of cancer cells comprising administering an effective amount of the composition of claim 1.

### Claim 16 (depends on 15)

The method of claim 15, wherein the cancer cells are a type selected from the group consisting of liver cancer, breast cancer, lung cancer, colon cancer, stomach cancer, pancreatic cancer, uterine cancer, prostate cancer, bone cancer, glioma, and leukemia.

### Claim 17 (depends on 2)

A method of increasing caspase-3 activity in a subject comprising administering an effective amount of the composition of claim 2 to the subject.

### Claim 18 (depends on 2)

A method of inhibiting growth of cancer cells comprising administering an effective amount of the composition of claim 2.

### Claim 19 (depends on 2)

The method of claim 2, wherein the cancer cells are a type selected from the group consisting of liver cancer, breast cancer, lung cancer, colon cancer, stomach cancer, pancreatic cancer, uterine cancer, prostate cancer, bone cancer, glioma, and leukemia.
